New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5716 | PF 06447475 | Potent LRRK2 inhibitor; neuroprotective |
| 5712 | 4-ethynyl-N-ethyl-1,8-naphthalimide | Click-activated fluorescent probe |
| 5684 | Naloxone 3-glucuronide carbonic acid salt | Naloxone conjugate |
| 5606 | LOC14 | High affinity protein disulfide isomerase (PDI) modulator |
| 5549 | Perlapine | Potent and selective hM3Dq DREADD agonist |
| 5517 | AMG PERK 44 | Potent and selective PERK inhibitor; orally bioavailable |
| 5512 | BIX NHE1 inhibitor | Potent and selective NHE1 inhibitor |
| 5471 | CGP 60474 | Potent dual cdk1/cdk2 inhibitor |
| 4845 | A 939572 | SCD1 inhibitor; induces cell death of undifferentiated human ESCs |
| 5582 | TAT-cyclo-CLLFVY | Selective HIF-1 dimerization inhibitor |
| 5559 | SSR 180711 hydrochloride | Partial agonist at α7 nAChR |
| 5472 | CGP 74514 dihydrochloride | Potent cdk1 inhibitor |